scispace - formally typeset
Open AccessJournal ArticleDOI

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Reads0
Chats0
TLDR
This AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B.
About
This article is published in Hepatology.The article was published on 2018-04-01 and is currently open access. It has received 2399 citations till now. The article focuses on the topics: Hepatitis B & Mass screening.

read more

Citations
More filters
Journal ArticleDOI

Hepatitis B virus recurrence after living donor liver transplantation of anti-HBc-positive grafts: A 22-year experience at a single center

TL;DR: HBV-naïve status may contribute to HBV recurrence after LDLT for HBV-unrelated liver disease from anti-HBc-positive donors, and careful monitoring for serological HBV markers is needed, particularly in this group.
Journal ArticleDOI

Improvements in the management of chronic hepatitis B virus infection.

TL;DR: The similarities and differences among the latest published regional guidelines on the indications and choices of antiviral therapy are compared and advances in virological biomarkers and non-invasive tests for liver fibrosis in disease assessment are summarized.
Journal ArticleDOI

Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease

- 15 May 2022 - 
TL;DR: Lee et al. as discussed by the authors proposed Gut and Liver 2022, a Gut-and-Liver publication for the first time, with a focus on the development of a new Gut-And Liver model.
Journal ArticleDOI

Role of HBsAg Testing in the Management of Patients with Chronic HBV

TL;DR: The clinical utility of HBsAg quantification in the management of chronic hepatitis B is updated and can serve as a therapeutic endpoint marker for evaluating novel curative agents against HBV infection.
References
More filters
Journal ArticleDOI

Management of hepatocellular carcinoma.

TL;DR: The prevention of Cirrhosis can prevent the development of HCC and progression from chronic HCV infection to advanced fibrosis or cirrhosis may be prevented in 40% of patients who are sustained responders to new antiviral strategies, such as pegylated interferon and ribavirin.
Journal ArticleDOI

AASLD guidelines for the treatment of hepatocellular carcinoma

TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about concrete mechanical properties such as E-modulus and compressive strength.
Journal ArticleDOI

Chronic hepatitis B: Update 2009

TL;DR: The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic Hepatitis B is now posted online at www.aasld.org, and the recommendation for first-line oral antiviral medications has been changed to tenofovir or entecavir, and adefovir has been moved to second-line Oral antiviral medication.
Journal ArticleDOI

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

TL;DR: More efficacious treatments, mass immunization programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV‐related morbidity and mortality.
Related Papers (5)

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer, +195 more